CO66 Reduction in Migraine-Associated Burden over 24 Weeks of Treatment with Eptinezumab in Patients with Chronic Migraine

P McAllister,D Kudrow,R Cady,J Hirman,A Ettrup

Value in Health（2022）

引用 0|浏览0

暂无评分

摘要

To examine changes in the occurrence, severity, and symptoms of headache episodes in patients with chronic migraine (CM) following eptinezumab treatment.

查看译文

关键词

eptinezumab,migraine-associated

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要